Kevin Mcnamara Sells 2,000 Shares of Chemed (NYSE:CHE) Stock

Chemed Corporation (NYSE:CHE) CEO Kevin Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $403.18, for a total transaction of $806,360.00. Following the completion of the sale, the chief executive officer owned 93,719 shares of the company’s stock, valued at approximately $37,785,626.42. The trade was a 2.09% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Chemed Stock Up 0.6%

Shares of NYSE:CHE traded up $2.31 during trading on Friday, reaching $401.86. 124,709 shares of the company traded hands, compared to its average volume of 203,754. The firm has a fifty day simple moving average of $441.92 and a 200 day simple moving average of $441.34. Chemed Corporation has a 1-year low of $385.00 and a 1-year high of $623.60. The firm has a market cap of $5.53 billion, a P/E ratio of 21.89, a price-to-earnings-growth ratio of 1.60 and a beta of 0.46.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Wednesday, February 25th. The company reported $6.42 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.02 by ($0.60). The firm had revenue of $639.34 million for the quarter, compared to analysts’ expectations of $659.09 million. Chemed had a return on equity of 25.66% and a net margin of 10.48%.Chemed’s revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the business posted $6.83 earnings per share. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. As a group, research analysts anticipate that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, March 13th. Stockholders of record on Monday, February 23rd will be paid a dividend of $0.60 per share. The ex-dividend date of this dividend is Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. Chemed’s dividend payout ratio (DPR) is 13.06%.

Wall Street Analyst Weigh In

Several analysts have commented on CHE shares. Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Jefferies Financial Group lowered shares of Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Oppenheimer lowered their target price on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, February 27th. Zacks Research lowered Chemed from a “hold” rating to a “strong sell” rating in a report on Wednesday, March 4th. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $422.00 price target (down from $572.00) on shares of Chemed in a research report on Friday, February 27th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $498.00.

Institutional Trading of Chemed

Institutional investors and hedge funds have recently modified their holdings of the company. Commonwealth Equity Services LLC boosted its holdings in shares of Chemed by 3.1% during the 4th quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock worth $314,000 after buying an additional 22 shares during the period. WCM Investment Management LLC lifted its position in Chemed by 3.8% during the 3rd quarter. WCM Investment Management LLC now owns 661 shares of the company’s stock worth $299,000 after acquiring an additional 24 shares during the last quarter. Eukles Asset Management boosted its holdings in Chemed by 0.4% during the third quarter. Eukles Asset Management now owns 6,031 shares of the company’s stock valued at $2,700,000 after acquiring an additional 24 shares during the period. Cim LLC boosted its holdings in Chemed by 1.1% during the third quarter. Cim LLC now owns 2,139 shares of the company’s stock valued at $958,000 after acquiring an additional 24 shares during the period. Finally, Cetera Investment Advisers grew its position in shares of Chemed by 1.5% in the second quarter. Cetera Investment Advisers now owns 1,740 shares of the company’s stock valued at $847,000 after purchasing an additional 25 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.